| Product Code: ETC13149382 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 5 Billion |
| Forecast Size (2032) | USD 7 Billion |
| CAGR | 5.20% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Magnetic Resonance Imaging (MRI) |
| Fastest Growing Segment | Positron Emission Tomography (PET) |
| Leading Companies | Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Bruker Corporation |

The Global Neuroimaging Market was estimated at USD 5 Billion in 2025 and is projected to reach USD 7 Billion by 2032, growing at a CAGR of 5.20% from 2026 to 2032.
Currently, the Global Neuroimaging Market is transforming significantly due to a surge in neurological disorder diagnoses and the concomitant need for precise imaging technologies. This trend is underscored by advancements such as high-resolution functional magnetic resonance imaging (fMRI) and adoptive machine learning algorithms, enhancing analytical capabilities in clinical settings.
The market's relevance extends beyond traditional clinical diagnostics; it increasingly intersects with fields like drug development and personalized medicine. This intersection represents a shift wherein neuroimaging techniques are pivotal not only for diagnosis but for monitoring treatment efficacy and predicting outcomes in complex conditions.
This graph illustrates the annual growth rates of the Global Neuroimaging Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 5.27 | A shift toward affordable raw materials impacts the growth of neuroimaging devices. |
| 2023 | 3.35 | Increasing patient outcomes data encourages hospitals to adopt advanced neuroimaging technologies. |
| 2024 | 6.83 | Hospitals in emerging markets increasingly invest in neuroimaging solutions for diagnostics. |
| 2025 | 5 | Expanding telehealth platforms enhances the accessibility of neuroimaging consultations and services. |
| 2026 | 5.77 | Sustainability concerns prompt healthcare providers to integrate eco-friendly neuroimaging practices. |
| 2027 | 4.02 | Medical device companies face challenges in sourcing neuroimaging components amid supply chain disruptions. |
| 2028 | 4.94 | Recent FDA approvals for novel neuroimaging tools are anticipated to stimulate market growth. |
| 2029 | 4.15 | Manufacturers are innovating neuroimaging technologies to improve chronic disease management capabilities. |
| 2030 | 6.03 | As competition intensifies, neuroimaging providers are enhancing service offerings to capture market share. |
| 2031 | 4.06 | In North America, increased M&A activity is shaping the future of neuroimaging solutions. |
| 2032 | 5.53 | Wearable monitoring devices advance neuroimaging methods, attracting skilled professionals to the sector. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Despite growth prospects, the Global Neuroimaging Market grapples with significant constraints, notably high costs associated with advanced imaging technologies. For instance, the installation of a high-end MRI system can exceed $1 million, creating a barrier for smaller health facilities and emerging markets. Moreover, the intricate nature of interpreting neuroimaging data poses challenges, as specialists are required to accurately analyze results, further complicating access. Regulatory hurdles concerning data privacy and the stringent requirements for compliance with imaging protocols limit operational flexibility for companies.
Two prominent trends are currently reshaping the Global Neuroimaging Market. First, the incorporation of artificial intelligence (AI) in neuroimaging analyses is revolutionizing the speed and accuracy of diagnoses. For instance, in 2021, Philips launched an AI-powered imaging platform that reduces interpretation time by up to 30%. Second, there is a marked shift toward non-invasive imaging techniques. As patients increasingly prefer procedures that minimize discomfort, technologies like fMRI and PET are gaining traction due to their non-invasive nature. This evolution is pushing research institutions to prioritize outcomes where imaging techniques contribute to better understanding and management of neurological conditions.
Future revenue opportunities in the Global Neuroimaging Market lie significantly within personalized medicine and mental health monitoring. For example, ongoing studies at Stanford University are exploring how neuroimaging can predict treatment outcomes for neurological disorders, potentially unlocking new market avenues. Furthermore, the development of portable imaging devices is expected to cater to underserved regions, creating an estimated market potential exceeding $1 billion by 2031. This shift towards accessibility reflects broader healthcare trends, where effort is concentrated on integrating advanced imaging technologies into routine patient care.
Magnetic Resonance Imaging (MRI) is the leading technology in the Global Neuroimaging Market, commanding approximately 55% share in 2025. It is favored for its superior imaging capabilities, especially in soft tissue differentiation. In contrast, Positron Emission Tomography (PET) is projected to be the fastest-growing segment, with a CAGR of 7.6% from 2026 to 2032. The growing prevalence of cancer and neurological diseases necessitates the enhanced diagnostic capabilities that PET offers, contributing significantly to its rapid growth.
The application segment of Neurological Disorders leads the Global Neuroimaging Market, holding about 60% share in 2025. The chronic rise in conditions such as Alzheimer's and Parkinson's drives this demand. However, the fastest-growing segment is anticipated to be Psychiatric Disorders, with a CAGR of 7.4% from 2026 to 2032. The increasing recognition of mental health issues and the integration of imaging techniques into psychiatric evaluation processes are pivotal factors influencing this growth.
Hospitals and Clinics represent the largest end-user segment in the Global Neuroimaging Market, with a share of approximately 65% in 2025. This dominance is attributed to their capability to invest in advanced imaging technologies and infrastructure. Meanwhile, Ambulatory Surgical Centers are poised to grow the fastest, with a CAGR of 6.5% from 2026 to 2032, driven by the increasing preference for outpatient procedures and the need for cost-effective diagnostic services.
North America stands as the largest region in the Global Neuroimaging Market, with around 42% share in 2025. The combination of advanced healthcare infrastructure and higher disposable incomes plays a crucial role in this market dominance. Meanwhile, Asia is expected to be the fastest-growing region, with a CAGR of 6.8% from 2026 to 2032. Rapid urbanization, increasing investments in healthcare facilities, and government initiatives to improve healthcare access are driving this substantial growth.
The regulatory and policy environment surrounding the Global Neuroimaging Market is continually evolving, aimed at enhancing healthcare delivery and accessibility. Various government bodies are spearheading initiatives that support advancements in neuroimaging technology and improve patient care standards.
The Global Neuroimaging Market is anticipated to witness transformative changes, particularly in AI integration and personalized medicine applications. Notably, companies like Siemens Healthineers are investing in AI algorithms that enhance imaging precision, which could redefine clinical practices. Forecasted advancements in portable imaging technology promise to improve access in underserved regions, further reshaping the competitive dynamics. By 2032, these shifts aim to expand neuroimaging's role from diagnostics to a comprehensive tool in patient management and treatment planning.
Ongoing advancements and initiatives in the Global Neuroimaging Market reflect a strong push toward enhancing technological capabilities, accessibility, and diagnostic power. The following developments capture key recent movements:
The Global Neuroimaging Market presents a fragmented landscape characterized by both established players and newer entrants developing niche technologies. Key companies leverage specialized expertise, regional strengths, and innovation to maintain competitive advantages.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Siemens Healthineers | Advanced diagnostic imaging technology | Investment in AI and patient-centered imaging solutions |
| GE Healthcare | Robust healthcare solutions across imaging and monitoring | Focus on digital healthcare transformation and operational efficiency |
| Philips Healthcare | Integrated healthcare systems and solutions | Advancing AI-driven technologies for diagnostic imaging |
| Canon Medical Systems | Innovative imaging modalities with high image quality | Enhancing accessibility of imaging solutions globally |
| Bruker Corporation | Expertise in imaging and analytical technologies | Development of advanced neuroimaging analytics and research tools |
As competition intensifies, strategic collaborations and technological breakthroughs will be pivotal for players in the Global Neuroimaging Market, enabling them to harness new opportunities and respond to evolving healthcare needs.
Global Neuroimaging Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neuroimaging Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neuroimaging Market Revenues & Volume, 2022 & 2032F |
3.3 Global Neuroimaging Market - Industry Life Cycle |
3.4 Global Neuroimaging Market - Porter's Five Forces |
3.5 Global Neuroimaging Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Neuroimaging Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 Global Neuroimaging Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Global Neuroimaging Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Global Neuroimaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neuroimaging Market Trends |
6 Global Neuroimaging Market, 2022-2032 |
6.1 Global Neuroimaging Market, Revenues & Volume, By Technology, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Neuroimaging Market, Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2022-2032 |
6.1.3 Global Neuroimaging Market, Revenues & Volume, By Computed Tomography (CT), 2022-2032 |
6.1.4 Global Neuroimaging Market, Revenues & Volume, By Positron Emission Tomography (PET), 2022-2032 |
6.1.5 Global Neuroimaging Market, Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2022-2032 |
6.1.6 Global Neuroimaging Market, Revenues & Volume, By Functional Magnetic Resonance Imaging (fMRI), 2022-2032 |
6.1.7 Global Neuroimaging Market, Revenues & Volume, By Diffusion Tensor Imaging (DTI), 2022-2032 |
6.1.8 Global Neuroimaging Market, Revenues & Volume, By Magnetoencephalography (MEG), 2022-2032 |
6.1.9 Global Neuroimaging Market, Revenues & Volume, By Others, 2022-2032 |
6.2 Global Neuroimaging Market, Revenues & Volume, By Application, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Neuroimaging Market, Revenues & Volume, By Neurological Disorders, 2022-2032 |
6.2.3 Global Neuroimaging Market, Revenues & Volume, By Psychiatric Disorders, 2022-2032 |
6.2.4 Global Neuroimaging Market, Revenues & Volume, By Traumatic Brain Injury (TBI), 2022-2032 |
6.3 Global Neuroimaging Market, Revenues & Volume, By End User, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Neuroimaging Market, Revenues & Volume, By Hospitals and Clinics, 2022-2032 |
6.3.3 Global Neuroimaging Market, Revenues & Volume, By Diagnostic Centers, 2022-2032 |
6.3.4 Global Neuroimaging Market, Revenues & Volume, By Research Institutes, 2022-2032 |
6.3.5 Global Neuroimaging Market, Revenues & Volume, By Ambulatory Surgical Centers, 2022-2032 |
6.3.6 Global Neuroimaging Market, Revenues & Volume, By Others, 2022-2032 |
7 North America Neuroimaging Market, Overview & Analysis |
7.1 North America Neuroimaging Market Revenues & Volume, 2022-2032 |
7.2 North America Neuroimaging Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Neuroimaging Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Neuroimaging Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Neuroimaging Market, Revenues & Volume, 2022-2032 |
7.3 North America Neuroimaging Market, Revenues & Volume, By Technology, 2022-2032 |
7.4 North America Neuroimaging Market, Revenues & Volume, By Application, 2022-2032 |
7.5 North America Neuroimaging Market, Revenues & Volume, By End User, 2022-2032 |
8 Latin America (LATAM) Neuroimaging Market, Overview & Analysis |
8.1 Latin America (LATAM) Neuroimaging Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Neuroimaging Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Neuroimaging Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Neuroimaging Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Neuroimaging Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By Technology, 2022-2032 |
8.4 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By Application, 2022-2032 |
8.5 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By End User, 2022-2032 |
9 Asia Neuroimaging Market, Overview & Analysis |
9.1 Asia Neuroimaging Market Revenues & Volume, 2022-2032 |
9.2 Asia Neuroimaging Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Neuroimaging Market, Revenues & Volume, 2022-2032 |
9.2.2 China Neuroimaging Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Neuroimaging Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Neuroimaging Market, Revenues & Volume, 2022-2032 |
9.3 Asia Neuroimaging Market, Revenues & Volume, By Technology, 2022-2032 |
9.4 Asia Neuroimaging Market, Revenues & Volume, By Application, 2022-2032 |
9.5 Asia Neuroimaging Market, Revenues & Volume, By End User, 2022-2032 |
10 Africa Neuroimaging Market, Overview & Analysis |
10.1 Africa Neuroimaging Market Revenues & Volume, 2022-2032 |
10.2 Africa Neuroimaging Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Neuroimaging Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Neuroimaging Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Neuroimaging Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Neuroimaging Market, Revenues & Volume, 2022-2032 |
10.3 Africa Neuroimaging Market, Revenues & Volume, By Technology, 2022-2032 |
10.4 Africa Neuroimaging Market, Revenues & Volume, By Application, 2022-2032 |
10.5 Africa Neuroimaging Market, Revenues & Volume, By End User, 2022-2032 |
11 Europe Neuroimaging Market, Overview & Analysis |
11.1 Europe Neuroimaging Market Revenues & Volume, 2022-2032 |
11.2 Europe Neuroimaging Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Neuroimaging Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Neuroimaging Market, Revenues & Volume, 2022-2032 |
11.2.3 France Neuroimaging Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Neuroimaging Market, Revenues & Volume, 2022-2032 |
11.3 Europe Neuroimaging Market, Revenues & Volume, By Technology, 2022-2032 |
11.4 Europe Neuroimaging Market, Revenues & Volume, By Application, 2022-2032 |
11.5 Europe Neuroimaging Market, Revenues & Volume, By End User, 2022-2032 |
12 Middle East Neuroimaging Market, Overview & Analysis |
12.1 Middle East Neuroimaging Market Revenues & Volume, 2022-2032 |
12.2 Middle East Neuroimaging Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Neuroimaging Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Neuroimaging Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Neuroimaging Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Neuroimaging Market, Revenues & Volume, By Technology, 2022-2032 |
12.4 Middle East Neuroimaging Market, Revenues & Volume, By Application, 2022-2032 |
12.5 Middle East Neuroimaging Market, Revenues & Volume, By End User, 2022-2032 |
13 Global Neuroimaging Market Key Performance Indicators |
14 Global Neuroimaging Market - Export/Import By Countries Assessment |
15 Global Neuroimaging Market - Opportunity Assessment |
15.1 Global Neuroimaging Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Neuroimaging Market Opportunity Assessment, By Technology, 2022 & 2032F |
15.3 Global Neuroimaging Market Opportunity Assessment, By Application, 2022 & 2032F |
15.4 Global Neuroimaging Market Opportunity Assessment, By End User, 2022 & 2032F |
16 Global Neuroimaging Market - Competitive Landscape |
16.1 Global Neuroimaging Market Revenue Share, By Companies, 2025 |
16.2 Global Neuroimaging Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here